Merit Medical Systems Inc
NASDAQ:MMSI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
65.53
105.33
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Merit Medical Systems Inc
Common Stock
Merit Medical Systems Inc
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Common Stock
$669.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
14%
|
||
Haemonetics Corp
NYSE:HAE
|
Common Stock
$504k
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
||
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Common Stock
$3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
||
ICU Medical Inc
NASDAQ:ICUI
|
Common Stock
$2.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
||
Align Technology Inc
NASDAQ:ALGN
|
Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Lantheus Holdings Inc
NASDAQ:LNTH
|
Common Stock
$709k
|
CAGR 3-Years
0%
|
CAGR 5-Years
12%
|
CAGR 10-Years
22%
|
Merit Medical Systems Inc
Glance View
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 6,446 full-time employees. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.
See Also
What is Merit Medical Systems Inc's Common Stock?
Common Stock
669.2m
USD
Based on the financial report for Sep 30, 2024, Merit Medical Systems Inc's Common Stock amounts to 669.2m USD.
What is Merit Medical Systems Inc's Common Stock growth rate?
Common Stock CAGR 10Y
14%
Over the last year, the Common Stock growth was -4%. The average annual Common Stock growth rates for Merit Medical Systems Inc have been 2% over the past three years , 3% over the past five years , and 14% over the past ten years .